Annovis Bio Inc.
Author: Michael
Eisai Co., Ltd. and Biogen Inc.
Longeveron Inc. held a Type C meeting with the U.
Alterity Therapeutics will deliver three presenta
Rznomics announced that the U.S.
Ahead of The Longevity Show, Steve Horvath expla
Neuraly-backed study explores whether a long-act
Voyager’s latest preclinical results suggest b
AI imaging expanded to routine scans, turning ev
Global teams gain funding and data access to ide